Lincoln Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
LINCOLN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lincoln Pharmaceuticals has informed the exchanges that its trading window will be closed from October 1, 2025, until 48 hours after the company announces its financial results for the quarter ended September 30, 2025. This is a standard compliance requirement under SEBI's Prohibition of Insider Trading Regulations, 2015. During this period, directors, senior management, promoters, promoter group members, their immediate relatives, and other connected persons are prohibited from trading in the company's shares. The date of the board meeting to approve the September-quarter results has not yet been disclosed and will be communicated separately.
This is a routine regulatory filing and does not indicate any material business event. The trading window closure signals that the Q2 FY26 earnings announcement is approaching, which investors should watch for. No immediate effect on share price is expected from this disclosure itself.